Healthcare Nov 11, 2020 10:42 AM (GMT+8) · EqualOcean
Suzhou-based pharmaceutical company Asieris announced Series D financing of CNY 700 million led by Qiming Venture Partners. Founded in 2010, the company develops first-in-class targeted therapy drugs for solid tumors, especially the bladder cancer. Asieris currently has six pipelines in progress with one entered the Phase III clinical trial.